letrozole has been researched along with Carcinoma, Pancreatic Ductal in 1 studies
Carcinoma, Pancreatic Ductal: Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xue, J | 1 |
| Yao, Y | 1 |
| Yao, Q | 1 |
| Tian, X | 1 |
| Feng, Y | 1 |
| Su, H | 1 |
| Kong, D | 1 |
| Cui, C | 1 |
| Yan, L | 1 |
| Hao, C | 1 |
| Zhou, T | 1 |
1 other study available for letrozole and Carcinoma, Pancreatic Ductal
| Article | Year |
|---|---|
Important roles of estrogen receptor alpha in tumor progression and anti-estrogen therapy of pancreatic ductal adenocarcinoma.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Pancreatic Ducta | 2020 |